Jérôme Schlué

3.1k total citations
64 papers, 2.1k citations indexed

About

Jérôme Schlué is a scholar working on Hepatology, Epidemiology and Genetics. According to data from OpenAlex, Jérôme Schlué has authored 64 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hepatology, 24 papers in Epidemiology and 20 papers in Genetics. Recurrent topics in Jérôme Schlué's work include Liver Disease Diagnosis and Treatment (21 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (18 papers) and Liver Diseases and Immunity (17 papers). Jérôme Schlué is often cited by papers focused on Liver Disease Diagnosis and Treatment (21 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (18 papers) and Liver Diseases and Immunity (17 papers). Jérôme Schlué collaborates with scholars based in Germany, United States and France. Jérôme Schlué's co-authors include Michael P. Manns, Heiner Wedemeyer, Hans Kreipe, R. Raupach, Richard Taubert, Elmar Jaeckel, Markus Cornberg, Matthias Hardtke‐Wolenski, Fatih Noyan and Oliver Bock and has published in prestigious journals such as PLoS ONE, Hepatology and Scientific Reports.

In The Last Decade

Jérôme Schlué

64 papers receiving 2.0k citations

Peers

Jérôme Schlué
Luisa Garcı́a-Buey Spain
Gianfranco Lauletta Italy
Etsuko Hashimoto Japan
Francesca Zorat Italy
Patricia M. Miron United States
Nabih Azar France
Daniela Zauli Italy
María‐Carlota Londoño Spain
Gian Lodovico Rapaccini Italy
John Karani United Kingdom
Luisa Garcı́a-Buey Spain
Jérôme Schlué
Citations per year, relative to Jérôme Schlué Jérôme Schlué (= 1×) peers Luisa Garcı́a-Buey

Countries citing papers authored by Jérôme Schlué

Since Specialization
Citations

This map shows the geographic impact of Jérôme Schlué's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme Schlué with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme Schlué more than expected).

Fields of papers citing papers by Jérôme Schlué

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérôme Schlué. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme Schlué. The network helps show where Jérôme Schlué may publish in the future.

Co-authorship network of co-authors of Jérôme Schlué

This figure shows the co-authorship network connecting the top 25 collaborators of Jérôme Schlué. A scholar is included among the top collaborators of Jérôme Schlué based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérôme Schlué. Jérôme Schlué is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dywicki, Janine, Laura Elisa Buitrago‐Molina, Anna Baumann, et al.. (2025). From model to man: Understanding Tregs' dual role in MASLD. JHEP Reports. 7(12). 101619–101619. 1 indexed citations
2.
Bartels, Stephan, Britta Hasemeier, Elisa Schipper, et al.. (2020). Feasibility of Combined Detection of Gene Mutations and Fusion Transcripts in Bone Marrow Trephines from Leukemic Neoplasms. Journal of Molecular Diagnostics. 22(4). 591–598. 4 indexed citations
3.
Bartels, Stephan, Muhammad Salman Faisal, Guntram Büsche, et al.. (2020). Knochenmarkfibrose bei primärer Myelofibrose in Abhängigkeit von myelodysplasie- und altersassoziierten Mutationen der Hämatopoese. Der Pathologe. 41(S2). 124–128. 1 indexed citations
4.
Wandrer, Franziska, et al.. (2018). Senescence mirrors the extent of liver fibrosis in chronic hepatitis C virus infection. Alimentary Pharmacology & Therapeutics. 48(3). 270–280. 27 indexed citations
5.
Diestelhorst, Jana, Norman Junge, Danny Jonigk, et al.. (2018). Baseline IL-2 and the AIH score can predict the response to standard therapy in paediatric autoimmune hepatitis. Scientific Reports. 8(1). 419–419. 13 indexed citations
6.
Hardtke‐Wolenski, Matthias, Janine Dywicki, Katja Fischer, et al.. (2016). The influence of genetic predisposition and autoimmune hepatitis inducing antigens in disease development. Journal of Autoimmunity. 78. 39–45. 21 indexed citations
7.
Schlué, Jérôme, et al.. (2016). Transfusion Independency and Histological Remission in a Patient with Advanced Primary Myelofibrosis Receiving Iron-Chelation Therapy with Deferasirox. Oncology Research and Treatment. 39(6). 384–387. 4 indexed citations
8.
Potthoff, Andrej, Dina Attia, Jérôme Schlué, et al.. (2015). Liver stiffness measurements and short-term survival after left ventricular assist device implantation: A pilot study. The Journal of Heart and Lung Transplantation. 34(12). 1586–1594. 18 indexed citations
9.
Taubert, Richard, Matthias Hardtke‐Wolenski, Fatih Noyan, et al.. (2014). Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies. Journal of Hepatology. 61(5). 1106–1114. 113 indexed citations
10.
Pischke, Sven, A. Gisa, Pothakamuri Venkata Suneetha, et al.. (2014). Increased HEV Seroprevalence in Patients with Autoimmune Hepatitis. PLoS ONE. 9(1). e85330–e85330. 56 indexed citations
11.
Pischke, Sven, Ilka Engelmann, Jérôme Schlué, et al.. (2012). High intrahepatic HHV-6 virus loads but neither CMV nor EBV are associated with decreased graft survival after diagnosis of graft hepatitis. Journal of Hepatology. 56(5). 1063–1069. 19 indexed citations
12.
13.
Boozari, B, B. Soudah, Kinan Rifai, et al.. (2011). Grading of hypervascular hepatocellular carcinoma using late phase of contrast enhanced sonography—A prospective study. Digestive and Liver Disease. 43(6). 484–490. 63 indexed citations
14.
Kröger, Nicolaus, Kais Hussein, Jérôme Schlué, et al.. (2010). Thrombospondin-1 (TSP-1) in primary myelofibrosis (PMF) — a megakaryocyte-derived biomarker which largely discriminates PMF from essential thrombocythemia. Annals of Hematology. 90(1). 33–40. 22 indexed citations
15.
Pischke, Sven, Andrej Potthoff, Bärbel Hauröder, et al.. (2010). Hepatitis E: Eine Infektionskrankheit erlebt einen Bedeutungswechsel. DMW - Deutsche Medizinische Wochenschrift. 135(22). 1129–1133. 12 indexed citations
16.
Ganzenmueller, Tina, Cornelia Henke‐Gendo, Jérôme Schlué, et al.. (2009). Quantification of cytomegalovirus DNA levels in intestinal biopsies as a diagnostic tool for CMV intestinal disease. Journal of Clinical Virology. 46(3). 254–258. 35 indexed citations
17.
Hussein, Kais, Oliver Bock, Katharina Theophile, et al.. (2009). JAK2V617F allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis. Experimental Hematology. 37(10). 1186–1193.e7. 52 indexed citations
18.
Pischke, Sven, Pothakamuri Venkata Suneetha, Christine Baechlein, et al.. (2009). Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transplantation. 16(1). 74–82. 149 indexed citations
19.
Wedemeyer, Jochen, M Gebel, Joachim Lotz, et al.. (2004). Malignant Lymphoma Accompanied by Renal Cell Carcinoma - A not so Rare Coincidence?. Ultraschall in der Medizin - European Journal of Ultrasound. 25(1). 65–69. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luisa Garcı́a-Buey Breakdown of academic impact, for papers by Gianfranco Lauletta Breakdown of academic impact, for papers by Etsuko Hashimoto Breakdown of academic impact, for papers by Francesca Zorat Breakdown of academic impact, for papers by Patricia M. Miron Breakdown of academic impact, for papers by Nabih Azar Breakdown of academic impact, for papers by Daniela Zauli Breakdown of academic impact, for papers by María‐Carlota Londoño Breakdown of academic impact, for papers by Gian Lodovico Rapaccini Breakdown of academic impact, for papers by John Karani
Rankless by CCL
2026